Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Biophysical Journal
|
April 12, 2018
Unwinding of the Substrate Transmembrane Helix in Intramembrane Proteolysis
Mia C Brown, Alaa Abdine, Jose Chavez, et al.
The Journal of Biological Chemistry
|
October 13, 2010
Gating of a G protein-sensitive mammalian Kir3.1 prokaryotic Kir channel chimera in planar lipid bilayers
Edgar Leal-Pinto, Yacob Gómez-Llorente, Shobana Sundaram, et al.
Nurse Leader
|
September 14, 2020
Multispecialty Nursing During COVID-19:: Lessons Learned in Southern California
Margo B Minissian, Jennifer Ballard-Hernandez, Bernice Coleman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 28, 2015
Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver Disease
Sarah Kattakuzhy, Eleanor Wilson, Sreetha Sidharthan, et al.
The Journal of Clinical Investigation
|
November 6, 2018
Biallelic mutations in DNA ligase 1 underlie a spectrum of immune deficiencies
Patrick Maffucci, Jose Chavez, Thomas J Jurkiw, et al.
Annals of Internal Medicine
|
November 24, 2015
Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection: An Open-Label, Nonrandomized Trial
Anita Kohli, Sarah Kattakuzhy, Sreetha Sidharthan, et al.
Rheumatology (Oxford, England)
|
June 12, 2019
Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial
Seung Cheol Shim, Ljubinka Božić-Majstorović, Alfredo Berrocal Kasay, et al.
The Journal of Surgical Research
|
July 3, 2022
A Multicenter Analysis of the Early Impact of COVID-19 on Junior Resident Operative Case Volume
Benjamin Kramer, Gilman Plitt, Judith C French, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
February 6, 2019
Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial
Chang-Hee Suh, Dae Hyun Yoo, Alfredo Berrocal Kasay, et al.
Mabs
|
July 17, 2018
Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial
Won Park, Ljubinka Božić-Majstorović, Dragana Milakovic, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Biophysical Journal
|
April 12, 2018
Unwinding of the Substrate Transmembrane Helix in Intramembrane Proteolysis
Mia C Brown, Alaa Abdine, Jose Chavez, et al.
The Journal of Biological Chemistry
|
October 13, 2010
Gating of a G protein-sensitive mammalian Kir3.1 prokaryotic Kir channel chimera in planar lipid bilayers
Edgar Leal-Pinto, Yacob Gómez-Llorente, Shobana Sundaram, et al.
Nurse Leader
|
September 14, 2020
Multispecialty Nursing During COVID-19:: Lessons Learned in Southern California
Margo B Minissian, Jennifer Ballard-Hernandez, Bernice Coleman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 28, 2015
Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver Disease
Sarah Kattakuzhy, Eleanor Wilson, Sreetha Sidharthan, et al.
The Journal of Clinical Investigation
|
November 6, 2018
Biallelic mutations in DNA ligase 1 underlie a spectrum of immune deficiencies
Patrick Maffucci, Jose Chavez, Thomas J Jurkiw, et al.
Annals of Internal Medicine
|
November 24, 2015
Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection: An Open-Label, Nonrandomized Trial
Anita Kohli, Sarah Kattakuzhy, Sreetha Sidharthan, et al.
Rheumatology (Oxford, England)
|
June 12, 2019
Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial
Seung Cheol Shim, Ljubinka Božić-Majstorović, Alfredo Berrocal Kasay, et al.
The Journal of Surgical Research
|
July 3, 2022
A Multicenter Analysis of the Early Impact of COVID-19 on Junior Resident Operative Case Volume
Benjamin Kramer, Gilman Plitt, Judith C French, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
February 6, 2019
Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial
Chang-Hee Suh, Dae Hyun Yoo, Alfredo Berrocal Kasay, et al.
Mabs
|
July 17, 2018
Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial
Won Park, Ljubinka Božić-Majstorović, Dragana Milakovic, et al.
Page
of 5